Which intubation method works best for acromegaly patients?
NCT ID NCT07659912
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how to safely place a breathing tube in people with acromegaly, a condition that can cause changes in the face and airway. It compares two methods: direct laryngoscopy and video laryngoscopy. The goal is to find which method gives a better view of the airway and reduces difficulty during intubation. Adults with acromegaly or nonfunctioning pituitary adenomas who need surgery under general anesthesia will take part.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better intubation guidelines for acromegaly patients, reducing complications during surgery.
- What could go wrong
- This is a small observational study with only 40 participants, so findings may not apply to all patients. It does not test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients with acromegaly or nonfunctioning pituitary adenoma who are evaluated by the institutional pituitary diseases council and scheduled for elective surgery under general anesthesia requiring endotracheal intubation at Basaksehir Cam and Sakura City Hospital.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 years or older * Diagnosis of acromegaly and scheduled for surgery after evaluation by the institutional pituitary diseases council * Diagnosis of nonfunctioning pituitary adenoma and scheduled for surgery after evaluation by the institutional pituitary diseases council * Requirement for general anesthesia with endotracheal intubation * Ability and willingness to provide written informed consent Exclusion Criteria: * Age younger than 18 years * Refusal to participate in the study * Presence of extrapituitary malignancy * Emergency surgery * Previous tracheostomy or major laryngeal/tracheal surgery * Severe limitation of mouth opening preventing standard laryngoscopic evaluation * Cervical spine instability or severe restriction of neck extension * Patients requiring awake fiberoptic intubation according to preoperative airway assessment * Patients for whom participation is considered unsafe by the responsible anesthesiologist
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acromegaly are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New Long-Acting shot takes aim at Acromegaly's hormone overload
- Can a Once-Monthly shot tame Acromegaly's hormone overdrive?
- Can a Growth-Hormone blocker stay safe in everyday use? a korean study investigates
- New octreotide pill faces off against current capsule in healthy volunteer study
- New software could improve acromegaly care
- New drug MAR002 aims to tame acromegaly in early trial